Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 4 de 4
1.
Nat Commun ; 9(1): 2825, 2018 07 19.
Article En | MEDLINE | ID: mdl-30026537

CD4 and chemokine receptors mediate HIV-1 attachment and entry. They are, however, insufficient to explain the preferential viral infection of central memory T cells. Here, we identify L-selectin (CD62L) as a viral adhesion receptor on CD4+ T cells. The binding of viral envelope glycans to L-selectin facilitates HIV entry and infection, and L-selectin expression on central memory CD4+ T cells supports their preferential infection by HIV. Upon infection, the virus downregulates L-selectin expression through shedding, resulting in an apparent loss of central memory CD4+ T cells. Infected effector memory CD4+ T cells, however, remain competent in cytokine production. Surprisingly, inhibition of L-selectin shedding markedly reduces HIV-1 infection and suppresses viral release, suggesting that L-selectin shedding is required for HIV-1 release. These findings highlight a critical role for cell surface sheddase in HIV-1 pathogenesis and reveal new antiretroviral strategies based on small molecular inhibitors targeted at metalloproteinases for viral release.


CD4-Positive T-Lymphocytes/immunology , HIV-1/immunology , Host-Pathogen Interactions , L-Selectin/genetics , Receptors, Virus/genetics , Virus Shedding/immunology , ADAM17 Protein/antagonists & inhibitors , ADAM17 Protein/genetics , ADAM17 Protein/immunology , Animals , Anti-HIV Agents/pharmacology , CD4-Positive T-Lymphocytes/drug effects , CD4-Positive T-Lymphocytes/virology , Dipeptides/pharmacology , HEK293 Cells , HIV Core Protein p24/antagonists & inhibitors , HIV Core Protein p24/genetics , HIV Core Protein p24/immunology , HIV Envelope Protein gp120/antagonists & inhibitors , HIV Envelope Protein gp120/genetics , HIV Envelope Protein gp120/immunology , HIV-1/drug effects , HIV-1/growth & development , HeLa Cells , Humans , Hydroxamic Acids/pharmacology , Immunologic Memory/drug effects , L-Selectin/antagonists & inhibitors , L-Selectin/immunology , Lymphocyte Activation/drug effects , Phenylalanine/analogs & derivatives , Phenylalanine/pharmacology , Primary Cell Culture , Protease Inhibitors/pharmacology , Receptors, Virus/antagonists & inhibitors , Receptors, Virus/immunology , Thiophenes/pharmacology , Virus Attachment/drug effects , Virus Internalization/drug effects , Virus Replication/drug effects , Virus Replication/immunology , Virus Shedding/drug effects
2.
J Leukoc Biol ; 91(2): 299-309, 2012 Feb.
Article En | MEDLINE | ID: mdl-22045868

NK cells control tumor and virus-infected cells through releasing cytotoxic granules and proinflammatory cytokines. IFN-γ and TNF-α secretions and cytotoxicity are regarded as two distinct functions of NK cells with little synergy in between as results of early association of the two functions with distinct subsets of NK populations and of the studies showing target cells developing NK resistance upon IFN-γ treatment. Here, we show that IFN-γ and TNF-α synergistically enhance NK cell cytotoxicity through NF-κB-dependent up-regulation of ICAM-1 expression in target cells, thereby promoting their conjugate formation with NK cells. Neutralizing IFN-γ and TNF-α during cytolysis significantly impaired NK cell lysis of the target cells. Further, tumor cells exhibiting IFN-γ-inducible lysis are generally less-sensitive NK target cells but express inducible levels of ICAM-1. In contrast, sensitive NK targets tend to express higher but less-inducible ICAM-1. Their preferential induction in the lysis of insensitive NK target cells suggests that IFN-γ and TNF-α are functionally linked to and should be regarded as an integral part of NK cytolytic function.


Cytotoxicity, Immunologic/physiology , Intercellular Adhesion Molecule-1/biosynthesis , Interferon-gamma/physiology , Killer Cells, Natural/immunology , Tumor Necrosis Factor-alpha/physiology , B7 Antigens/biosynthesis , B7 Antigens/genetics , Cell Line, Tumor , Drug Synergism , GPI-Linked Proteins/biosynthesis , GPI-Linked Proteins/genetics , Gene Expression Regulation , HLA Antigens/biosynthesis , HLA Antigens/genetics , Humans , Intercellular Adhesion Molecule-1/genetics , Intercellular Signaling Peptides and Proteins/biosynthesis , Intercellular Signaling Peptides and Proteins/genetics , Interferon-gamma/biosynthesis , Interferon-gamma/genetics , Intracellular Signaling Peptides and Proteins/genetics , Killer Cells, Natural/metabolism , NF-kappa B/metabolism , RNA, Small Interfering/pharmacology , Recombinant Fusion Proteins/physiology , Transfection , Tumor Necrosis Factor-alpha/biosynthesis , Tumor Necrosis Factor-alpha/genetics , Up-Regulation
3.
Structure ; 18(8): 934-43, 2010 Aug 11.
Article En | MEDLINE | ID: mdl-20696394

The B cell antigen receptor (BCR) plays an essential role in all phases of B cell development. Here we show that the extracellular domains of murine and human Igbeta form an I-set immunoglobulin-like structure with an interchain disulfide between cysteines on their G strands. Structural and sequence analysis suggests that Igalpha displays a similar fold as Igbeta. An Igalphabeta heterodimer model was generated based on the unique disulfide-bonded Igbeta dimer. Solution binding studies showed that the extracellular domains of Igalphabeta preferentially recognize the constant region of BCR with mu chain specificity, suggesting a role for Igalphabeta to enhance BCRmu chain signaling. Cluster mutations on Igalpha, Igbeta, and a membrane-bound form of immunoglobulin (mIgM) based on the structural model identified distinct areas of potential contacts involving charged residues on both subunits of the coreceptor and the Cmu4 domain of mIgM. These studies provide the first structural model for understanding BCR function.


CD79 Antigens/chemistry , Models, Molecular , Protein Conformation , Receptors, Antigen, B-Cell/chemistry , Amino Acid Sequence , Animals , Base Sequence , CD79 Antigens/metabolism , Crystallography , DNA Mutational Analysis , DNA Primers/genetics , Dimerization , Humans , Mice , Molecular Sequence Data , Protein Folding , Receptors, Antigen, B-Cell/metabolism , Sequence Alignment , Species Specificity , Surface Plasmon Resonance
4.
Protein Expr Purif ; 74(2): 248-56, 2010 Dec.
Article En | MEDLINE | ID: mdl-20600944

Factors affecting protein expression have been intensely studied to the benefit of recombinant protein production. Through mutational analysis at the +2 amino acid position of recombinant Igα, we examined the effect of all 20 amino acids on protein expression. The results showed that amino acids at the +2 position affected 10-fold in the recombinant protein expression. Specifically, Ala, Cys, Pro, Ser, Thr, and Lys at the +2 position resulted in significantly higher expression of recombinant Igα than other amino acids, while Met, His and Glu resulted in greatly reduced protein expression. This expression difference depended on the amino acid instead of their codon usage. Consistent with the mutational results, a statistically significant enrichment in Ala and Ser at the +2 position was observed among highly expressed Escherichia coli genes. This work suggests a general approach to enhance protein expression by incorporating an Ala or Ser after the initiation codon.


Codon, Initiator , Protein Biosynthesis , Recombinant Proteins/chemistry , Amino Acid Sequence , Chemokine CXCL10/chemistry , Chemokine CXCL10/genetics , Escherichia coli/genetics , Humans , Immunoglobulin A/chemistry , Immunoglobulin A/genetics , Immunoglobulin A/metabolism , Recombinant Proteins/genetics
...